RCKT Long Put Strategy
RCKT (Rocket Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at specific genetic conditions: Fanconi anemia, characterized by a bone marrow defect that hinders blood cell production; leukocyte adhesion deficiency-I, an inherited disorder resulting in a compromised immune system; and pyruvate kinase deficiency, a rare autosomal recessive red blood cell ailment leading to chronic non-spherocytic hemolytic anemia. Complementing these, Rocket Pharmaceuticals also has an in vivo adeno-associated virus program underway for Danon disease, a serious multi-organ lysosomal storage disorder that tragically often results in early mortality due to heart failure. To facilitate its extensive research and development efforts, the company has established key licensing partnerships with esteemed institutions such as the Fred Hutchinson Cancer Research Center, European research bodies including CIEMAT and its collaborators (Centro de Investigacion Biomedica En Red and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz), UCL Business PLC (in conjunction with CIEMAT), The Regents of the University of California, and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. maintains its primary corporate location in Cranbury, New Jersey.
RCKT (Rocket Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $354.9M, a beta of 0.47 versus the broader market, a 52-week range of 2.4-5.45, average daily share volume of 3.1M, a public-listing history dating back to 2015, approximately 299 full-time employees. These structural characteristics shape how RCKT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.47 indicates RCKT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on RCKT?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current RCKT snapshot
As of June 30, 2026, spot at $3.40, ATM IV 133.80%, IV rank 26.37%, expected move 38.36%. The long put on RCKT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long put structure on RCKT specifically: RCKT IV at 133.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a RCKT long put, with a market-implied 1-standard-deviation move of approximately 38.36% (roughly $1.30 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RCKT expiries trade a higher absolute premium for lower per-day decay. Position sizing on RCKT should anchor to the underlying notional of $3.40 per share and to the trader's directional view on RCKT stock.
RCKT long put setup
The RCKT long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RCKT near $3.40, the first option leg uses a $3.40 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RCKT chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RCKT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $3.40 | N/A |
RCKT long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
RCKT long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on RCKT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on RCKT
Long puts on RCKT hedge an existing long RCKT stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying RCKT exposure being hedged.
RCKT thesis for this long put
The market-implied 1-standard-deviation range for RCKT extends from approximately $2.10 on the downside to $4.70 on the upside. A RCKT long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long RCKT position with one put per 100 shares held. Current RCKT IV rank near 26.37% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RCKT at 133.80%. As a Healthcare name, RCKT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RCKT-specific events.
RCKT long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RCKT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RCKT alongside the broader basket even when RCKT-specific fundamentals are unchanged. Long-premium structures like a long put on RCKT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current RCKT chain quotes before placing a trade.
Frequently asked questions
- What is a long put on RCKT?
- A long put on RCKT is the long put strategy applied to RCKT (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With RCKT stock trading near $3.40, the strikes shown on this page are snapped to the nearest listed RCKT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are RCKT long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the RCKT long put priced from the end-of-day chain at a 30-day expiry (ATM IV 133.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RCKT long put?
- The breakeven for the RCKT long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RCKT market-implied 1-standard-deviation expected move is approximately 38.36%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on RCKT?
- Long puts on RCKT hedge an existing long RCKT stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying RCKT exposure being hedged.
- How does current RCKT implied volatility affect this long put?
- RCKT ATM IV is at 133.80% with IV rank near 26.37%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.